ID   DEPD5_HUMAN             Reviewed;        1603 AA.
AC   O75140; A6H8V6; A8MPX9; B4DH93; B9EGN9; Q5K3V5; Q5THY9; Q5THZ0; Q5THZ1;
AC   Q5THZ3; Q68DR1; Q6MZX3; Q6PEZ1; Q9UGV8; Q9UH13;
DT   03-APR-2002, integrated into UniProtKB/Swiss-Prot.
DT   29-MAY-2013, sequence version 2.
DT   28-JUN-2023, entry version 188.
DE   RecName: Full=GATOR complex protein DEPDC5 {ECO:0000305};
DE   AltName: Full=DEP domain-containing protein 5 {ECO:0000312|HGNC:HGNC:18423};
GN   Name=DEPDC5 {ECO:0000312|HGNC:HGNC:18423};
GN   Synonyms=KIAA0645 {ECO:0000312|EMBL:BAA31620.2};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 4 AND 9).
RC   TISSUE=Cerebellum;
RX   PubMed=15770670; DOI=10.1002/gcc.20181;
RA   Seng T.J., Ichimura K., Liu L., Tingby O., Pearson D.M., Collins V.P.;
RT   "Complex chromosome 22 rearrangements in astrocytic tumors identified using
RT   microsatellite and chromosome 22 tile path array analysis.";
RL   Genes Chromosomes Cancer 43:181-193(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=9734811; DOI=10.1093/dnares/5.3.169;
RA   Ishikawa K., Nagase T., Suyama M., Miyajima N., Tanaka A., Kotani H.,
RA   Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. X. The
RT   complete sequences of 100 new cDNA clones from brain which can code for
RT   large proteins in vitro.";
RL   DNA Res. 5:169-176(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 8).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M., Clamp M.,
RA   Smink L.J., Ainscough R., Almeida J.P., Babbage A.K., Bagguley C.,
RA   Bailey J., Barlow K.F., Bates K.N., Beasley O.P., Bird C.P., Blakey S.E.,
RA   Bridgeman A.M., Buck D., Burgess J., Burrill W.D., Burton J., Carder C.,
RA   Carter N.P., Chen Y., Clark G., Clegg S.M., Cobley V.E., Cole C.G.,
RA   Collier R.E., Connor R., Conroy D., Corby N.R., Coville G.J., Cox A.V.,
RA   Davis J., Dawson E., Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M.,
RA   Ellington A.G., Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S., Hunt S.E.,
RA   Jones M.C., Kershaw J., Kimberley A.M., King A., Laird G.K., Langford C.F.,
RA   Leversha M.A., Lloyd C., Lloyd D.M., Martyn I.D., Mashreghi-Mohammadi M.,
RA   Matthews L.H., Mccann O.T., Mcclay J., Mclaren S., McMurray A.A.,
RA   Milne S.A., Mortimore B.J., Odell C.N., Pavitt R., Pearce A.V., Pearson D.,
RA   Phillimore B.J.C.T., Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y.,
RA   Rogers L., Ross M.T., Scott C.E., Sehra H.K., Skuce C.D., Smalley S.,
RA   Smith M.L., Soderlund C., Spragon L., Steward C.A., Sulston J.E.,
RA   Swann R.M., Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J., Shintani A.,
RA   Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S., Roe B.A., Chen F., Chu L.,
RA   Crabtree J., Deschamps S., Do A., Do T., Dorman A., Fang F., Fu Y., Hu P.,
RA   Hua A., Kenton S., Lai H., Lao H.I., Lewis J., Lewis S., Lin S.-P., Loh P.,
RA   Malaj E., Nguyen T., Pan H., Phan S., Qi S., Qian Y., Ray L., Ren Q.,
RA   Shaull S., Sloan D., Song L., Wang Q., Wang Y., Wang Z., White J.,
RA   Willingham D., Wu H., Yao Z., Zhan M., Zhang G., Chissoe S., Murray J.,
RA   Miller N., Minx P., Fulton R., Johnson D., Bemis G., Bentley D.,
RA   Bradshaw H., Bourne S., Cordes M., Du Z., Fulton L., Goela D., Graves T.,
RA   Hawkins J., Hinds K., Kemp K., Latreille P., Layman D., Ozersky P.,
RA   Rohlfing T., Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K.,
RA   Nelson J., Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S., Budarf M.L.,
RA   McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E., Edelmann L., Kim U.J.,
RA   Shizuya H., Simon M.I., Dumanski J.P., Peyrard M., Kedra D., Seroussi E.,
RA   Fransson I., Tapia I., Bruder C.E., O'Brien K.P., Wilkinson P.,
RA   Bodenteich A., Hartman K., Hu X., Khan A.S., Lane L., Tilahun Y.,
RA   Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 10).
RC   TISSUE=Placenta, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 571-1603 (ISOFORM 6), AND
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 604-1603 (ISOFORM 9).
RC   TISSUE=Fetal brain;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   FUNCTION, IDENTIFICATION IN GATOR COMPLEX, AND SUBUNIT.
RX   PubMed=23723238; DOI=10.1126/science.1232044;
RA   Bar-Peled L., Chantranupong L., Cherniack A.D., Chen W.W., Ottina K.A.,
RA   Grabiner B.C., Spear E.D., Carter S.L., Meyerson M., Sabatini D.M.;
RT   "A Tumor suppressor complex with GAP activity for the Rag GTPases that
RT   signal amino acid sufficiency to mTORC1.";
RL   Science 340:1100-1106(2013).
RN   [10]
RP   FUNCTION.
RX   PubMed=25457612; DOI=10.1016/j.celrep.2014.10.019;
RA   Parmigiani A., Nourbakhsh A., Ding B., Wang W., Kim Y.C., Akopiants K.,
RA   Guan K.L., Karin M., Budanov A.V.;
RT   "Sestrins inhibit mTORC1 kinase activation through the GATOR complex.";
RL   Cell Rep. 9:1281-1291(2014).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-505, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12]
RP   SUBCELLULAR LOCATION.
RX   PubMed=28199306; DOI=10.1038/nature21423;
RA   Wolfson R.L., Chantranupong L., Wyant G.A., Gu X., Orozco J.M., Shen K.,
RA   Condon K.J., Petri S., Kedir J., Scaria S.M., Abu-Remaileh M.,
RA   Frankel W.N., Sabatini D.M.;
RT   "KICSTOR recruits GATOR1 to the lysosome and is necessary for nutrients to
RT   regulate mTORC1.";
RL   Nature 543:438-442(2017).
RN   [13]
RP   FUNCTION, INTERACTION WITH KLHL22, DOMAIN, UBIQUITINATION BY KLHL22, AND
RP   MUTAGENESIS OF LYS-447; LYS-710; LYS-1065; LYS-1088; SER-1188; THR-1189;
RP   SER-1195; SER-1201; TYR-1203; SER-1207; THR-1223; THR-1241; SER-1244;
RP   THR-1250; TYR-1253; TYR-1256 AND LYS-1574.
RX   PubMed=29769719; DOI=10.1038/s41586-018-0128-9;
RA   Chen J., Ou Y., Yang Y., Li W., Xu Y., Xie Y., Liu Y.;
RT   "KLHL22 activates amino-acid-dependent mTORC1 signalling to promote
RT   tumorigenesis and ageing.";
RL   Nature 557:585-589(2018).
RN   [14]
RP   INVOLVEMENT IN FFEVF1, AND VARIANTS FFEVF1 ASP-214; PRO-542; PRO-1081;
RP   PHE-1154 AND GLN-1268.
RX   PubMed=26505888; DOI=10.1002/ana.24547;
RG   Epilepsy Electroclinical Study Group;
RA   Ricos M.G., Hodgson B.L., Pippucci T., Saidin A., Ong Y.S., Heron S.E.,
RA   Licchetta L., Bisulli F., Bayly M.A., Hughes J., Baldassari S., Palombo F.,
RA   Santucci M., Meletti S., Berkovic S.F., Rubboli G., Thomas P.Q.,
RA   Scheffer I.E., Tinuper P., Geoghegan J., Schreiber A.W., Dibbens L.M.;
RT   "Mutations in the mammalian target of rapamycin pathway regulators NPRL2
RT   and NPRL3 cause focal epilepsy.";
RL   Ann. Neurol. 79:120-131(2016).
RN   [15]
RP   INVOLVEMENT IN FFEVF1, AND VARIANT FFEVF1 ARG-1065.
RX   PubMed=27173016; DOI=10.1111/epi.13391;
RA   Weckhuysen S., Marsan E., Lambrecq V., Marchal C., Morin-Brureau M.,
RA   An-Gourfinkel I., Baulac M., Fohlen M., Kallay Zetchi C., Seeck M.,
RA   de la Grange P., Dermaut B., Meurs A., Thomas P., Chassoux F., Leguern E.,
RA   Picard F., Baulac S.;
RT   "Involvement of GATOR complex genes in familial focal epilepsies and focal
RT   cortical dysplasia.";
RL   Epilepsia 57:994-1003(2016).
RN   [16]
RP   VARIANTS FFEVF1 VAL-452; ARG-1073 AND LEU-1104, AND INVOLVEMENT IN FFEVF1.
RX   PubMed=23542697; DOI=10.1038/ng.2599;
RA   Dibbens L.M., de Vries B., Donatello S., Heron S.E., Hodgson B.L.,
RA   Chintawar S., Crompton D.E., Hughes J.N., Bellows S.T., Klein K.M.,
RA   Callenbach P.M., Corbett M.A., Gardner A.E., Kivity S., Iona X.,
RA   Regan B.M., Weller C.M., Crimmins D., O'Brien T.J., Guerrero-Lopez R.,
RA   Mulley J.C., Dubeau F., Licchetta L., Bisulli F., Cossette P., Thomas P.Q.,
RA   Gecz J., Serratosa J., Brouwer O.F., Andermann F., Andermann E.,
RA   van den Maagdenberg A.M., Pandolfo M., Berkovic S.F., Scheffer I.E.;
RT   "Mutations in DEPDC5 cause familial focal epilepsy with variable foci.";
RL   Nat. Genet. 45:546-551(2013).
RN   [17]
RP   VARIANT FFEVF1 GLN-485, AND TISSUE SPECIFICITY.
RX   PubMed=23542701; DOI=10.1038/ng.2601;
RA   Ishida S., Picard F., Rudolf G., Noe E., Achaz G., Thomas P., Genton P.,
RA   Mundwiller E., Wolff M., Marescaux C., Miles R., Baulac M., Hirsch E.,
RA   Leguern E., Baulac S.;
RT   "Mutations of DEPDC5 cause autosomal dominant focal epilepsies.";
RL   Nat. Genet. 45:552-555(2013).
RN   [18]
RP   VARIANTS FFEVF1 ILE-90 AND LEU-272.
RX   PubMed=24591017; DOI=10.1002/ana.24127;
RA   Lal D., Reinthaler E.M., Schubert J., Muhle H., Riesch E., Kluger G.,
RA   Jabbari K., Kawalia A., Baumel C., Holthausen H., Hahn A., Feucht M.,
RA   Neophytou B., Haberlandt E., Becker F., Altmuller J., Thiele H.,
RA   Lemke J.R., Lerche H., Nurnberg P., Sander T., Weber Y., Zimprich F.,
RA   Neubauer B.A.;
RT   "DEPDC5 mutations in genetic focal epilepsies of childhood.";
RL   Ann. Neurol. 75:788-792(2014).
RN   [19]
RP   VARIANT FFEVF1 MET-864.
RX   PubMed=24283814; DOI=10.1111/cge.12311;
RA   Martin C., Meloche C., Rioux M.F., Nguyen D.K., Carmant L., Andermann E.,
RA   Gravel M., Cossette P.;
RT   "A recurrent mutation in DEPDC5 predisposes to focal epilepsies in the
RT   French-Canadian population.";
RL   Clin. Genet. 86:570-574(2014).
RN   [20]
RP   VARIANTS FFEVF1 ILE-90; LEU-272; VAL-452; GLN-485; MET-864; ARG-1073 AND
RP   GLY-1162, CHARACTERIZATION OF VARIANTS FFEVF1 ILE-90; LEU-272; VAL-452;
RP   GLN-485; MET-864; ARG-1073 AND GLY-1162, AND IDENTIFICATION IN GATOR
RP   COMPLEX.
RX   PubMed=25366275; DOI=10.1002/humu.22723;
RA   van Kranenburg M., Hoogeveen-Westerveld M., Nellist M.;
RT   "Preliminary functional assessment and classification of DEPDC5 variants
RT   associated with focal epilepsy.";
RL   Hum. Mutat. 36:200-209(2015).
CC   -!- FUNCTION: As a component of the GATOR1 complex functions as an
CC       inhibitor of the amino acid-sensing branch of the TORC1 pathway. The
CC       GATOR1 complex strongly increases GTP hydrolysis by RRAGA and RRAGB
CC       within RRAGC-containing heterodimers, thereby deactivating RRAGs,
CC       releasing mTORC1 from lysosomal surface and inhibiting mTORC1
CC       signaling. The GATOR1 complex is negatively regulated by GATOR2 the
CC       other GATOR subcomplex in this amino acid-sensing branch of the TORC1
CC       pathway. {ECO:0000269|PubMed:23723238, ECO:0000269|PubMed:25457612,
CC       ECO:0000269|PubMed:29769719}.
CC   -!- SUBUNIT: Within the GATOR complex, component of the GATOR1 subcomplex,
CC       made of DEPDC5, NPRL2 and NPRL3. GATOR1 mediates the strong interaction
CC       of the GATOR complex with RRAGA/RRAGC and RRAGB/RRAGC heterodimers.
CC       Interacts (via DEP domain) with KLHL22; the interaction depends on
CC       amino acid availability (PubMed:29769719).
CC       {ECO:0000269|PubMed:23723238, ECO:0000269|PubMed:25366275,
CC       ECO:0000269|PubMed:29769719}.
CC   -!- INTERACTION:
CC       O75140-2; P49368: CCT3; NbExp=3; IntAct=EBI-12366971, EBI-356673;
CC       O75140-2; Q6W0C5: DPPA3; NbExp=3; IntAct=EBI-12366971, EBI-12082590;
CC       O75140-2; Q13257: MAD2L1; NbExp=3; IntAct=EBI-12366971, EBI-78203;
CC       O75140-2; Q9UI95: MAD2L2; NbExp=3; IntAct=EBI-12366971, EBI-77889;
CC       O75140-2; Q6FHY5: MEOX2; NbExp=3; IntAct=EBI-12366971, EBI-16439278;
CC       O75140-2; Q96QG7: MTMR9; NbExp=3; IntAct=EBI-12366971, EBI-744593;
CC       O75140-2; Q9BSW7: SYT17; NbExp=3; IntAct=EBI-12366971, EBI-745392;
CC       O75140-2; O75604: USP2; NbExp=3; IntAct=EBI-12366971, EBI-743272;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol
CC       {ECO:0000250|UniProtKB:P61460}. Cytoplasm, perinuclear region
CC       {ECO:0000250|UniProtKB:P61460}. Lysosome membrane
CC       {ECO:0000269|PubMed:28199306}. Note=Localization to lysosomes is amino
CC       acid-independent. {ECO:0000269|PubMed:28199306}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=8;
CC       Name=10;
CC         IsoId=O75140-10; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O75140-2; Sequence=VSP_014933, VSP_014934;
CC       Name=4;
CC         IsoId=O75140-4; Sequence=VSP_014938;
CC       Name=5;
CC         IsoId=O75140-5; Sequence=VSP_014941;
CC       Name=6;
CC         IsoId=O75140-6; Sequence=VSP_014936, VSP_014939, VSP_014940;
CC       Name=8;
CC         IsoId=O75140-8; Sequence=VSP_014936, VSP_014938;
CC       Name=9;
CC         IsoId=O75140-9; Sequence=VSP_014937;
CC       Name=1;
CC         IsoId=O75140-1; Sequence=VSP_014937, VSP_014938;
CC   -!- TISSUE SPECIFICITY: Expressed in developing and adult brain.
CC       {ECO:0000269|PubMed:23542701}.
CC   -!- DOMAIN: The DEP domain mediates the interaction with KLHL22.
CC       {ECO:0000269|PubMed:29769719}.
CC   -!- PTM: Ubiquitinated. Amino acid-induced 'Lys-48'-linked
CC       polyubiquitination of DEPDC5 by the BCR(KLHL22) ubiquitin ligase
CC       complex leads to DEPDC5 proteasomal degradation and inhibition of the
CC       GATOR1 complex (PubMed:29769719). Ubiquitination may occur at multiple
CC       lysines (PubMed:29769719). {ECO:0000269|PubMed:29769719}.
CC   -!- DISEASE: Epilepsy, familial focal, with variable foci 1 (FFEVF1)
CC       [MIM:604364]: An autosomal dominant form of epilepsy characterized by
CC       focal seizures arising from different cortical regions in different
CC       family members. Many patients have an aura and show automatisms during
CC       the seizures, whereas others may have nocturnal seizures. There is
CC       often secondary generalization. Some patients show abnormal interictal
CC       EEG, and some patients may have intellectual disability or autism
CC       spectrum disorders. Seizure onset usually occurs in the first or second
CC       decades, although later onset has been reported, and there is
CC       phenotypic variability within families. Penetrance of the disorder is
CC       incomplete. {ECO:0000269|PubMed:23542697, ECO:0000269|PubMed:23542701,
CC       ECO:0000269|PubMed:24283814, ECO:0000269|PubMed:24591017,
CC       ECO:0000269|PubMed:25366275, ECO:0000269|PubMed:26505888,
CC       ECO:0000269|PubMed:27173016}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Note=Inactivating mutations and truncating deletions in the
CC       genes encoding GATOR1 proteins, including DEPDC5, are detected in
CC       glioblastoma and ovarian tumors and are associated with loss of
CC       heterozygosity events. Inactivation of GATOR1 proteins promotes
CC       constitutive localization of mTORC1 to the lysosomal membrane and
CC       blocks mTORC1 inactivation following amino acid withdrawal
CC       (PubMed:23723238). {ECO:0000269|PubMed:23723238}.
CC   -!- MISCELLANEOUS: [Isoform 6]: May be produced at very low levels due to a
CC       premature stop codon in the mRNA, leading to nonsense-mediated mRNA
CC       decay. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the IML1 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA31620.2; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=CAG27890.1; Type=Miscellaneous discrepancy; Note=Aberrant splicing.; Evidence={ECO:0000305};
CC       Sequence=CAH18159.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ698950; CAG27889.1; -; mRNA.
DR   EMBL; AJ698951; CAG27890.1; ALT_SEQ; mRNA.
DR   EMBL; AJ704764; CAG28924.1; -; mRNA.
DR   EMBL; AB014545; BAA31620.2; ALT_INIT; mRNA.
DR   EMBL; AK294987; BAG58054.1; -; mRNA.
DR   EMBL; AC005004; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL022331; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z83856; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z82190; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471095; EAW59996.1; -; Genomic_DNA.
DR   EMBL; BC057797; AAH57797.1; -; mRNA.
DR   EMBL; BC136612; AAI36613.1; -; mRNA.
DR   EMBL; BC146766; AAI46767.1; -; mRNA.
DR   EMBL; BX640828; CAE45904.1; -; mRNA.
DR   EMBL; CR749304; CAH18159.1; ALT_INIT; mRNA.
DR   CCDS; CCDS43006.1; -. [O75140-1]
DR   CCDS; CCDS43007.1; -. [O75140-2]
DR   CCDS; CCDS46692.1; -. [O75140-9]
DR   CCDS; CCDS56229.1; -. [O75140-8]
DR   CCDS; CCDS74849.1; -. [O75140-10]
DR   CCDS; CCDS87017.1; -. [O75140-4]
DR   PIR; T00376; T00376.
DR   RefSeq; NP_001007189.1; NM_001007188.2. [O75140-2]
DR   RefSeq; NP_001129501.1; NM_001136029.2. [O75140-9]
DR   RefSeq; NP_001229825.1; NM_001242896.1. [O75140-10]
DR   RefSeq; NP_001229826.1; NM_001242897.1. [O75140-8]
DR   RefSeq; NP_055477.1; NM_014662.4. [O75140-1]
DR   RefSeq; XP_005261919.1; XM_005261862.1.
DR   RefSeq; XP_011528859.1; XM_011530557.2. [O75140-9]
DR   RefSeq; XP_011528860.1; XM_011530558.2.
DR   RefSeq; XP_011528861.1; XM_011530559.2.
DR   RefSeq; XP_011528865.1; XM_011530563.2. [O75140-8]
DR   RefSeq; XP_016884598.1; XM_017029109.1.
DR   RefSeq; XP_016884599.1; XM_017029110.1.
DR   RefSeq; XP_016884600.1; XM_017029111.1.
DR   PDB; 6CES; EM; 4.00 A; D=1-1603.
DR   PDB; 6CET; EM; 4.40 A; D=1-1603.
DR   PDB; 7T3A; EM; 4.00 A; A=1-1603.
DR   PDB; 7T3B; EM; 3.90 A; A=1-1603.
DR   PDB; 7T3C; EM; 4.00 A; A=1-1603.
DR   PDBsum; 6CES; -.
DR   PDBsum; 6CET; -.
DR   PDBsum; 7T3A; -.
DR   PDBsum; 7T3B; -.
DR   PDBsum; 7T3C; -.
DR   AlphaFoldDB; O75140; -.
DR   SMR; O75140; -.
DR   BioGRID; 115034; 67.
DR   ComplexPortal; CPX-6226; GATOR1 complex.
DR   CORUM; O75140; -.
DR   DIP; DIP-62050N; -.
DR   IntAct; O75140; 25.
DR   MINT; O75140; -.
DR   STRING; 9606.ENSP00000383105; -.
DR   GlyCosmos; O75140; 1 site, 1 glycan.
DR   GlyGen; O75140; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; O75140; -.
DR   PhosphoSitePlus; O75140; -.
DR   BioMuta; DEPDC5; -.
DR   EPD; O75140; -.
DR   jPOST; O75140; -.
DR   MassIVE; O75140; -.
DR   MaxQB; O75140; -.
DR   PaxDb; O75140; -.
DR   PeptideAtlas; O75140; -.
DR   ProteomicsDB; 1924; -.
DR   ProteomicsDB; 49795; -. [O75140-10]
DR   ProteomicsDB; 49796; -. [O75140-2]
DR   ProteomicsDB; 49798; -. [O75140-4]
DR   ProteomicsDB; 49799; -. [O75140-5]
DR   ProteomicsDB; 49800; -. [O75140-6]
DR   ProteomicsDB; 49802; -. [O75140-8]
DR   ABCD; O75140; 1 sequenced antibody.
DR   Antibodypedia; 65139; 78 antibodies from 20 providers.
DR   DNASU; 9681; -.
DR   Ensembl; ENST00000382111.6; ENSP00000371545.2; ENSG00000100150.20. [O75140-5]
DR   Ensembl; ENST00000382112.8; ENSP00000371546.4; ENSG00000100150.20. [O75140-10]
DR   Ensembl; ENST00000400242.8; ENSP00000383101.3; ENSG00000100150.20. [O75140-2]
DR   Ensembl; ENST00000400248.7; ENSP00000383107.1; ENSG00000100150.20. [O75140-1]
DR   Ensembl; ENST00000400249.7; ENSP00000383108.3; ENSG00000100150.20. [O75140-4]
DR   Ensembl; ENST00000535622.6; ENSP00000440210.1; ENSG00000100150.20. [O75140-8]
DR   Ensembl; ENST00000642696.1; ENSP00000495917.1; ENSG00000100150.20. [O75140-1]
DR   Ensembl; ENST00000644331.1; ENSP00000494406.1; ENSG00000100150.20. [O75140-4]
DR   Ensembl; ENST00000645711.1; ENSP00000493489.1; ENSG00000100150.20. [O75140-9]
DR   Ensembl; ENST00000646755.1; ENSP00000496532.1; ENSG00000100150.20. [O75140-2]
DR   Ensembl; ENST00000651528.2; ENSP00000498382.1; ENSG00000100150.20. [O75140-10]
DR   GeneID; 9681; -.
DR   KEGG; hsa:9681; -.
DR   MANE-Select; ENST00000651528.2; ENSP00000498382.1; NM_001242896.3; NP_001229825.1.
DR   UCSC; uc003alr.3; human. [O75140-10]
DR   AGR; HGNC:18423; -.
DR   CTD; 9681; -.
DR   DisGeNET; 9681; -.
DR   GeneCards; DEPDC5; -.
DR   GeneReviews; DEPDC5; -.
DR   HGNC; HGNC:18423; DEPDC5.
DR   HPA; ENSG00000100150; Low tissue specificity.
DR   MalaCards; DEPDC5; -.
DR   MIM; 604364; phenotype.
DR   MIM; 614191; gene.
DR   neXtProt; NX_O75140; -.
DR   OpenTargets; ENSG00000100150; -.
DR   Orphanet; 101046; Autosomal dominant epilepsy with auditory features.
DR   Orphanet; 98784; Autosomal dominant nocturnal frontal lobe epilepsy.
DR   Orphanet; 98820; Familial focal epilepsy with variable foci.
DR   PharmGKB; PA134864958; -.
DR   VEuPathDB; HostDB:ENSG00000100150; -.
DR   eggNOG; KOG3572; Eukaryota.
DR   GeneTree; ENSGT00390000016559; -.
DR   HOGENOM; CLU_004411_0_0_1; -.
DR   InParanoid; O75140; -.
DR   OMA; REMWHFE; -.
DR   OrthoDB; 946033at2759; -.
DR   PathwayCommons; O75140; -.
DR   Reactome; R-HSA-9639288; Amino acids regulate mTORC1.
DR   SignaLink; O75140; -.
DR   SIGNOR; O75140; -.
DR   BioGRID-ORCS; 9681; 44 hits in 1171 CRISPR screens.
DR   ChiTaRS; DEPDC5; human.
DR   GeneWiki; DEPDC5; -.
DR   GenomeRNAi; 9681; -.
DR   Pharos; O75140; Tbio.
DR   PRO; PR:O75140; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   RNAct; O75140; protein.
DR   Bgee; ENSG00000100150; Expressed in paraflocculus and 149 other tissues.
DR   ExpressionAtlas; O75140; baseline and differential.
DR   Genevisible; O75140; HS.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:1990130; C:GATOR1 complex; IDA:SGD.
DR   GO; GO:0005765; C:lysosomal membrane; IDA:UniProtKB.
DR   GO; GO:0005764; C:lysosome; IDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW.
DR   GO; GO:0044877; F:protein-containing complex binding; IDA:UniProtKB.
DR   GO; GO:0034198; P:cellular response to amino acid starvation; IMP:UniProtKB.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:InterPro.
DR   GO; GO:0032007; P:negative regulation of TOR signaling; IMP:SGD.
DR   GO; GO:1904262; P:negative regulation of TORC1 signaling; IMP:UniProtKB.
DR   GO; GO:0010508; P:positive regulation of autophagy; IBA:GO_Central.
DR   CDD; cd04449; DEP_DEPDC5-like; 1.
DR   Gene3D; 1.10.10.10; Winged helix-like DNA-binding domain superfamily/Winged helix DNA-binding domain; 1.
DR   InterPro; IPR000591; DEP_dom.
DR   InterPro; IPR045838; DEPDC5_CTD.
DR   InterPro; IPR027244; IML1.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   PANTHER; PTHR13179; DEP DOMAIN CONTAINING PROTEIN 5; 1.
DR   PANTHER; PTHR13179:SF8; GATOR COMPLEX PROTEIN DEPDC5; 1.
DR   Pfam; PF00610; DEP; 1.
DR   Pfam; PF19418; DEPDC5_CTD; 1.
DR   Pfam; PF12257; IML1; 1.
DR   SMART; SM00049; DEP; 1.
DR   SUPFAM; SSF46785; Winged helix' DNA-binding domain; 1.
DR   PROSITE; PS50186; DEP; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cytoplasm; Disease variant; Epilepsy;
KW   GTPase activation; Lysosome; Membrane; Phosphoprotein; Reference proteome;
KW   Ubl conjugation.
FT   CHAIN           1..1603
FT                   /note="GATOR complex protein DEPDC5"
FT                   /id="PRO_0000079865"
FT   DOMAIN          1187..1262
FT                   /note="DEP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00066"
FT   REGION          427..450
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          484..527
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          696..720
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1135..1165
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        427..443
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        495..527
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         505
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   VAR_SEQ         556..559
FT                   /note="DVLE -> EHLG (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_014933"
FT   VAR_SEQ         560..1603
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_014934"
FT   VAR_SEQ         624..701
FT                   /note="Missing (in isoform 6 and isoform 8)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:17974005"
FT                   /id="VSP_014936"
FT   VAR_SEQ         724..733
FT                   /note="ILTLSAPPVV -> M (in isoform 1 and isoform 9)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:15770670, ECO:0000303|PubMed:17974005,
FT                   ECO:0000303|PubMed:9734811"
FT                   /id="VSP_014937"
FT   VAR_SEQ         1089..1110
FT                   /note="Missing (in isoform 1, isoform 4 and isoform 8)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:15770670,
FT                   ECO:0000303|PubMed:9734811"
FT                   /id="VSP_014938"
FT   VAR_SEQ         1230..1338
FT                   /note="IMQKMLEEQLITHASGEAWRTFIYGFYFYKIVTDKEPDRVAMQQPATTWHTA
FT                   GVDDFASFQRKWFEVAFVAEELVHSEIPAFLLPWLPSRPASYASRHSSFSRSFGGRS
FT                   -> VMQWPCSSPPPPGTQQEWTTSPASSASGLRWPLWQKSSCTLRFLPFSCPGCLTGQP
FT                   PMQVGTAPLAEVLEDGARRQHF (in isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_014939"
FT   VAR_SEQ         1339..1603
FT                   /note="Missing (in isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_014940"
FT   VAR_SEQ         1460..1603
FT                   /note="FEPETYWDRMHLFQEAIAHRFGFVQDKYSASAFNFPAENKPQYIHVTGTVFL
FT                   QLPYSKRKFSGQQRRRRNSTSSTNQNMFCEERVGYNWAYNTMLTKTWRSSATGDEKFAD
FT                   RLLKDFTDFCINRDNRLVTFWTSCLEKMHASAP -> LGLYKINILPLLLTSLLRTSLS
FT                   ISTLQEQCFCSCPTPSASSQGSSGGGGTPPAPPTRTCSARSGSATTGPTTPCSPKHGAP
FT                   APQGMKSLLIGC (in isoform 5)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_014941"
FT   VARIANT         90
FT                   /note="V -> I (in FFEVF1; does not inhibit DEPDC5
FT                   signaling; does not change kinase activity of mTORC1; does
FT                   not change association with the GATOR complex; inhibits
FT                   slightly RRAGA/RRAGC and RRAGB/RRAGC heterodimer formation;
FT                   dbSNP:rs768456731)"
FT                   /evidence="ECO:0000269|PubMed:24591017,
FT                   ECO:0000269|PubMed:25366275"
FT                   /id="VAR_072363"
FT   VARIANT         214
FT                   /note="H -> D (in FFEVF1; unknown pathological
FT                   significance; dbSNP:rs886039276)"
FT                   /evidence="ECO:0000269|PubMed:26505888"
FT                   /id="VAR_077128"
FT   VARIANT         272
FT                   /note="V -> L (in FFEVF1; does not inhibit DEPDC5
FT                   signaling; does not change kinase activity of mTORC1; does
FT                   not change association with the GATOR complex; does not
FT                   change RRAGA/RRAGC and RRAGB/RRAGC heterodimer formation;
FT                   dbSNP:rs187334123)"
FT                   /evidence="ECO:0000269|PubMed:24591017,
FT                   ECO:0000269|PubMed:25366275"
FT                   /id="VAR_072364"
FT   VARIANT         452
FT                   /note="A -> V (in FFEVF1; inhibits slightly DEPDC5
FT                   signaling; stimulates slightly kinase activity of mTORC1;
FT                   does not change association with the GATOR complex; does
FT                   not change RRAGA/RRAGC and RRAGB/RRAGC heterodimer
FT                   formation; dbSNP:rs202226316)"
FT                   /evidence="ECO:0000269|PubMed:23542697,
FT                   ECO:0000269|PubMed:25366275"
FT                   /id="VAR_069263"
FT   VARIANT         485
FT                   /note="R -> Q (in FFEVF1; does not inhibit DEPDC5
FT                   signaling; stimulates slightly kinase activity of mTORC1;
FT                   does not change association with the GATOR complex; does
FT                   not change RRAGA/RRAGC and RRAGB/RRAGC heterodimer
FT                   formation; dbSNP:rs886039278)"
FT                   /evidence="ECO:0000269|PubMed:23542701,
FT                   ECO:0000269|PubMed:25366275"
FT                   /id="VAR_069264"
FT   VARIANT         491
FT                   /note="S -> T (in dbSNP:rs8138516)"
FT                   /id="VAR_024338"
FT   VARIANT         542
FT                   /note="Q -> P (in FFEVF1; unknown pathological
FT                   significance; dbSNP:rs886039279)"
FT                   /evidence="ECO:0000269|PubMed:26505888"
FT                   /id="VAR_077129"
FT   VARIANT         641
FT                   /note="A -> V (in dbSNP:rs16989528)"
FT                   /id="VAR_053953"
FT   VARIANT         712
FT                   /note="S -> F (in dbSNP:rs16989535)"
FT                   /id="VAR_053954"
FT   VARIANT         864
FT                   /note="T -> M (in FFEVF1; inhibits slightly DEPDC5
FT                   signaling; does not change kinase activity of mTORC1; does
FT                   not change association with the GATOR complex; does not
FT                   change RRAGA/RRAGC and RRAGB/RRAGC heterodimer formation;
FT                   dbSNP:rs564667614)"
FT                   /evidence="ECO:0000269|PubMed:24283814,
FT                   ECO:0000269|PubMed:25366275"
FT                   /id="VAR_072365"
FT   VARIANT         1065
FT                   /note="K -> R (in FFEVF1; unknown pathological
FT                   significance; dbSNP:rs757609394)"
FT                   /evidence="ECO:0000269|PubMed:27173016"
FT                   /id="VAR_077130"
FT   VARIANT         1073
FT                   /note="S -> R (in FFEVF1; inhibits slightly DEPDC5
FT                   signaling; does not change kinase activity of mTORC1; does
FT                   not change association with the GATOR complex; does not
FT                   change RRAGA/RRAGC and RRAGB/RRAGC heterodimer formation;
FT                   dbSNP:rs754608531)"
FT                   /evidence="ECO:0000269|PubMed:23542697,
FT                   ECO:0000269|PubMed:25366275"
FT                   /id="VAR_069265"
FT   VARIANT         1081
FT                   /note="T -> P (in FFEVF1; unknown pathological
FT                   significance; dbSNP:rs142540948)"
FT                   /evidence="ECO:0000269|PubMed:26505888"
FT                   /id="VAR_077131"
FT   VARIANT         1104
FT                   /note="S -> L (in FFEVF1; unknown pathological
FT                   significance; dbSNP:rs79027628)"
FT                   /evidence="ECO:0000269|PubMed:23542697"
FT                   /id="VAR_069266"
FT   VARIANT         1154
FT                   /note="S -> F (in FFEVF1; unknown pathological
FT                   significance; dbSNP:rs578244490)"
FT                   /evidence="ECO:0000269|PubMed:26505888"
FT                   /id="VAR_077132"
FT   VARIANT         1162
FT                   /note="S -> G (in FFEVF1; does not inhibit DEPDC5
FT                   signaling; does not change kinase activity of mTORC1; does
FT                   not change association with the GATOR complex; does not
FT                   change RRAGA/RRAGC and RRAGB/RRAGC heterodimer formation;
FT                   dbSNP:rs886039280)"
FT                   /evidence="ECO:0000269|PubMed:25366275"
FT                   /id="VAR_072366"
FT   VARIANT         1268
FT                   /note="R -> Q (in FFEVF1; unknown pathological
FT                   significance; dbSNP:rs886039281)"
FT                   /evidence="ECO:0000269|PubMed:26505888"
FT                   /id="VAR_077133"
FT   MUTAGEN         447
FT                   /note="K->R: No effect on ubiquitination. Loss of
FT                   interaction with KLHL22 and ubiquitination; when associated
FT                   with R-710, R-1065, R-1088 and R-1574."
FT                   /evidence="ECO:0000269|PubMed:29769719"
FT   MUTAGEN         710
FT                   /note="K->R: No effect on ubiquitination. Loss of
FT                   interaction with KLHL22 and ubiquitination; when associated
FT                   with R-447, R-1065, R-1088 and R-1574."
FT                   /evidence="ECO:0000269|PubMed:29769719"
FT   MUTAGEN         1065
FT                   /note="K->R: No effect on ubiquitination. Loss of
FT                   interaction with KLHL22 and ubiquitination; when associated
FT                   with R-447, R-710, R-1088 and R-1574."
FT                   /evidence="ECO:0000269|PubMed:29769719"
FT   MUTAGEN         1088
FT                   /note="K->R: No effect on ubiquitination. Loss of
FT                   interaction with KLHL22 and ubiquitination; when associated
FT                   with R-447, R-710, R-1065 and R-1574."
FT                   /evidence="ECO:0000269|PubMed:29769719"
FT   MUTAGEN         1188
FT                   /note="S->A: No effect on interaction with KLHL22."
FT                   /evidence="ECO:0000269|PubMed:29769719"
FT   MUTAGEN         1189
FT                   /note="T->A: No effect on interaction with KLHL22."
FT                   /evidence="ECO:0000269|PubMed:29769719"
FT   MUTAGEN         1195
FT                   /note="S->A: No effect on interaction with KLHL22."
FT                   /evidence="ECO:0000269|PubMed:29769719"
FT   MUTAGEN         1201
FT                   /note="S->A: No effect on interaction with KLHL22."
FT                   /evidence="ECO:0000269|PubMed:29769719"
FT   MUTAGEN         1203
FT                   /note="Y->A: No effect on interaction with KLHL22."
FT                   /evidence="ECO:0000269|PubMed:29769719"
FT   MUTAGEN         1207
FT                   /note="S->A: No effect on interaction with KLHL22."
FT                   /evidence="ECO:0000269|PubMed:29769719"
FT   MUTAGEN         1223
FT                   /note="T->A: No effect on interaction with KLHL22."
FT                   /evidence="ECO:0000269|PubMed:29769719"
FT   MUTAGEN         1241
FT                   /note="T->A: No effect on interaction with KLHL22."
FT                   /evidence="ECO:0000269|PubMed:29769719"
FT   MUTAGEN         1244
FT                   /note="S->A: No effect on interaction with KLHL22."
FT                   /evidence="ECO:0000269|PubMed:29769719"
FT   MUTAGEN         1250
FT                   /note="T->A: No effect on interaction with KLHL22."
FT                   /evidence="ECO:0000269|PubMed:29769719"
FT   MUTAGEN         1253
FT                   /note="Y->A: No effect on interaction with KLHL22."
FT                   /evidence="ECO:0000269|PubMed:29769719"
FT   MUTAGEN         1256
FT                   /note="Y->A: No effect on interaction with KLHL22."
FT                   /evidence="ECO:0000269|PubMed:29769719"
FT   MUTAGEN         1574
FT                   /note="K->R: No effect on ubiquitination. Loss of
FT                   ubiquitination; when associated with R-447, R-710, R-1065
FT                   and R-1088."
FT                   /evidence="ECO:0000269|PubMed:29769719"
FT   CONFLICT        1365
FT                   /note="D -> G (in Ref. 7; CAH18159)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1430
FT                   /note="L -> P (in Ref. 7; CAH18159)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1561
FT                   /note="S -> G (in Ref. 7; CAH18159)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1603 AA;  181264 MW;  19664228B566A080 CRC64;
     MRTTKVYKLV IHKKGFGGSD DELVVNPKVF PHIKLGDIVE IAHPNDEYSP LLLQVKSLKE
     DLQKETISVD QTVTQVFRLR PYQDVYVNVV DPKDVTLDLV ELTFKDQYIG RGDMWRLKKS
     LVSTCAYITQ KVEFAGIRAQ AGELWVKNEK VMCGYISEDT RVVFRSTSAM VYIFIQMSCE
     MWDFDIYGDL YFEKAVNGFL ADLFTKWKEK NCSHEVTVVL FSRTFYDAKS VDEFPEINRA
     SIRQDHKGRF YEDFYKVVVQ NERREEWTSL LVTIKKLFIQ YPVLVRLEQA EGFPQGDNST
     SAQGNYLEAI NLSFNVFDKH YINRNFDRTG QMSVVITPGV GVFEVDRLLM ILTKQRMIDN
     GIGVDLVCMG EQPLHAVPLF KLHNRSAPRD SRLGDDYNIP HWINHSFYTS KSQLFCNSFT
     PRIKLAGKKP ASEKAKNGRD TSLGSPKESE NALPIQVDYD AYDAQVFRLP GPSRAQCLTT
     CRSVRERESH SRKSASSCDV SSSPSLPSRT LPTEEVRSQA SDDSSLGKSA NILMIPHPHL
     HQYEVSSSLG YTSTRDVLEN MMEPPQRDSS APGRFHVGSA ESMLHVRPGG YTPQRALINP
     FAPSRMPMKL TSNRRRWMHT FPVGPSGEAI QIHHQTRQNM AELQGSGQRD PTHSSAELLE
     LAYHEAAGRH SNSRQPGDGM SFLNFSGTEE LSVGLLSNSG AGMNPRTQNK DSLEDSVSTS
     PDPILTLSAP PVVPGFCCTV GVDWKSLTTP ACLPLTTDYF PDRQGLQNDY TEGCYDLLPE
     ADIDRRDEDG VQMTAQQVFE EFICQRLMQG YQIIVQPKTQ KPNPAVPPPL SSSPLYSRGL
     VSRNRPEEED QYWLSMGRTF HKVTLKDKMI TVTRYLPKYP YESAQIHYTY SLCPSHSDSE
     FVSCWVEFSH ERLEEYKWNY LDQYICSAGS EDFSLIESLK FWRTRFLLLP ACVTATKRIT
     EGEAHCDIYG DRPRADEDEW QLLDGFVRFV EGLNRIRRRH RSDRMMRKGT AMKGLQMTGP
     ISTHSLESTA PPVGKKGTSA LSALLEMEAS QKCLGEQQAA VHGGKSSAQS AESSSVAMTP
     TYMDSPRKDG AFFMEFVRSP RTASSAFYPQ VSVDQTATPM LDGTSLGICT GQSMDRGNSQ
     TFGNSQNIGE QGYSSTNSSD SSSQQLVASS LTSSSTLTEI LEAMKHPSTG VQLLSEQKGL
     SPYCFISAEV VHWLVNHVEG IQTQAMAIDI MQKMLEEQLI THASGEAWRT FIYGFYFYKI
     VTDKEPDRVA MQQPATTWHT AGVDDFASFQ RKWFEVAFVA EELVHSEIPA FLLPWLPSRP
     ASYASRHSSF SRSFGGRSQA AALLAATVPE QRTVTLDVDV NNRTDRLEWC SCYYHGNFSL
     NAAFEIKLHW MAVTAAVLFE MVQGWHRKAT SCGFLLVPVL EGPFALPSYL YGDPLRAQLF
     IPLNISCLLK EGSEHLFDSF EPETYWDRMH LFQEAIAHRF GFVQDKYSAS AFNFPAENKP
     QYIHVTGTVF LQLPYSKRKF SGQQRRRRNS TSSTNQNMFC EERVGYNWAY NTMLTKTWRS
     SATGDEKFAD RLLKDFTDFC INRDNRLVTF WTSCLEKMHA SAP
//
